Participated in FDA's Pharmacy Compounding Advisory Committee Key Concerns: Manufacturing quality and consistency; Peptide purity and impurities; Bacterial endotoxin control; Heavy metals and residual solvents; Potency and stability testing; Independent lot testing; Chain-of-custody documentation; and Accurate labeling and appropriate use information.
2026 · 3rd Quarter (July 1 - Sep 30)
AMERICAN COUNCIL OF PEPTIDES
Filed by OSCAR POLICY GROUP, LLC.
Open official filingSource-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Oct 5, 2026
- Income
- $20,000.00
- Expenses
- Not reported
- Registrant
- OSCAR POLICY GROUP, LLC
- Filing UUID
- 5519b3fa-f373-454d-86a7-d61a5d4da27b
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.